Peripheral Blood Monocyte Sirt1 Expression Is Reduced in Patients with Coronary Artery Disease

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Breitenstein, Alexander ^a,b   Wyss, Christophe A ^a,b   Spescha, Remo D ^b   Franzeck, Fabian C ^b   Hof, Danielle ^b   Riwanto, Meliana ^b   Hasun, Matthias ^a,b   Akhmedov, Alexander ^a,b   von Eckardstein, Arnold ^b,c   Maier, Willibald ^a,b   Landmesser, Ulf ^a,b   Lüscher, Thomas F ^a,b   Camici, Giovanni G ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; MESSENGER RNA; SIRTUIN 1;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; GENE EXPRESSION; HEART CATHETERIZATION; HUMAN; HUMAN CELL; MALE; MOLECULAR PATHOLOGY; MONOCYTE; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ACUTE CORONARY SYNDROME; AGED; ARYLDIALKYLPHOSPHATASE; CORONARY ARTERY DISEASE; GENE EXPRESSION REGULATION; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MONOCYTES; SIRTUIN 1;

EID: 84873809257     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053106     Document Type: Article

References (19)

1. Thygesen K, Alpert JS, White HD, (2007) Universal definition of myocardial infarction. J Am Coll Cardiol 50: 2173-2195.
2. Ross R, (1995) Cell biology of atherosclerosis. Annu Rev Physiol 57: 791-804.
3. Maier W, Altwegg LA, Corti R, Gay S, Hersberger M, et al. (2005) Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein. Circulation 111: 1355-1361.
4. Gasser SM, Cockell MM, (2001) The molecular biology of the SIR proteins. Gene 279: 1-16.
5. Breitenstein A, Stein S, Holy EW, Camici GG, Lohmann C, et al. (2011) Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells. Cardiovasc Res 89: 464-472.
6. Stein S, Lohmann C, Schafer N, Hofmann J, Rohrer L, et al. (2010) SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis. Eur Heart J 31: 2301-2309.
7. Breitenstein A, Stampfli SF, Camici GG, Akhmedov A, Ha HR, et al. (2008) Amiodarone Inhibits Arterial Thrombus Formation and Tissue Factor Translation. Arterioscler Thromb Vasc Biol 28: 2231-2238.
8. Havel RJ, Eder HA, Bragdon JH, (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353.
9. Besler C, Heinrich K, Rohrer L, Doerries C, Riwanto M, et al. (2011) Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest 121: 2693-2708.
10. Camici GG, Steffel J, Akhmedov A, Schafer N, Baldinger J, et al. (2006) Dimethyl sulfoxide inhibits tissue factor expression, thrombus formation, and vascular smooth muscle cell activation: a potential treatment strategy for drug-eluting stents. Circulation 114: 1512-1521.
11. Zhu X, Liu Q, Wang M, Liang M, Yang X, et al. (2011) Activation of Sirt1 by resveratrol inhibits TNF-alpha induced inflammation in fibroblasts. PLoS One 6: e27081.
12. Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, et al. (2008) Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. Jama 299: 1265-1276.
13. Zhang QJ, Wang Z, Chen HZ, Zhou S, Zheng W, et al. (2008) Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res 80: 191-199.
14. Barter PJ, Caulfield M, Eriksson M, Grundy SM, Kastelein JJ, et al. (2007) Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 357: 2109-2122.
15. Terasaka N, Yu S, Yvan-Charvet L, Wang N, Mzhavia N, et al. (2008) ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet. J Clin Invest 118: 3701-3713.
16. Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, et al. (2006) High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res. 98: 63-72.
17. Mineo C, Deguchi H, Griffin JH, Shaul PW, (2006) Endothelial and antithrombotic actions of HDL. Circ Res 98: 1352-1364.
18. Ansell BJ, Navab M, Hama S, Kamranpour N, Fonarow G, et al. (2003) Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation 108: 2751-2756.
19. Mackness B, Quarck R, Verreth W, Mackness M, Holvoet P, (2006) Human paraoxonase-1 overexpression inhibits atherosclerosis in a mouse model of metabolic syndrome. Arterioscler Thromb Vasc Biol 26: 1545-1550.